Liminatus Pharma, Inc. (LIMN) stock

LIMNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMNW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$2.99+0.22 (+7.94%)

Close on Nov 13, 2026Market cap $200.81MP/E –Yield –

Liminatus Pharma statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $200.81M; $272.32M
Enterprise Value: $199.24M; $146.23M
PB Ratio: 668.00; 2.00
P/TBV Ratio: 668.00; 2.22

Share statisticsIndustry

Shares Outstanding: 67M; 58M
Shares Change (YoY): 82.7%; 10.8%
Shares Change (QoQ): 24.7%; 0.50%
Float: 41M; 49M
Shares Held by Insiders: 38.7%; 11.7%
Shares Held by Institutions: 2.34%; 56.4%

Short sellingIndustry

Short Interest: 47,913; –
Short Interest Change: 20.9%; -0.80%
Days to Cover: 1.65; 5.15

Stock price statisticsIndustry

52-Week High: $141.50; –
52-Week Low: $2.40; –
20-Day Moving Average: $2.88; –
50-Day Moving Average: $3.36; –
200-Day Moving Average: $9.46; –
Average True Range (14): $0.32; –
Price Change (1 Week): 17.7%; -1.15%
Price Change (1 Month): -6.85%; -4.87%
Price Change (3 Months): -57.7%; -21.0%
Price Change (6 Months): -66.8%; -20.6%
Price Change (YTD): -90.2%; -23.6%
Price Change (1 Year): -94.9%; -22.4%
Price Change (3 Years): -99.4%; -29.5%
Price Change (5 Years): -99.4%; -77.9%
Average Volume (10 Days): 33,237; –
Average Volume (20 Days): 31,871; –
Average Volume (90 Days): 330,801; –
Relative Volume: 0.04; 0.70
Relative Strength Index (14): 48.4; 43.4
Volatility (1 Year): 178.7%; 80.1%
Beta (5 Years): 0.78; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -471.5%; -40.6%
Return on Capital Employed (ROCE): -1119.0%; -37.9%

Financial positionIndustry

Current Ratio: 1.12; 3.30
Quick Ratio: 0.99; 2.39
Debt / Equity: 4.80; 0.49
Interest Coverage: -53.78; -6.35

EfficiencyIndustry

Profits Per Employee: -$12.52M; -$689.41K
Employee Count: 1; 74
WACC: 8.95%; 10.2%

Income statement (TTM)Industry

Operating Income: -$4.07M; -$21.37M
Net Income: -$12.52M; -$22.35M
EBITDA: -$4.07M; -$17.21M
EPS (Diluted): -$0.43; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $3.02M; $68.68M
Total Debt: $1.44M; $116.91M
Net Cash (Debt): $1.57M; $17.76M
Net Cash Per Share: $0.02; $0.80
Equity (Book Value): $300.61K; $53.89M
Book Value Per Share: $0.00; $1.50
Tangible Book Value: $300.61K; $27.13M
Working Capital: $352.04K; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$3.97M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -6.24%; -21.8%

Taxes and interestIndustry

Interest Expense: $75.59K; $2.90M

Scores and fair valueIndustry

Altman Z-Score: 17.98; 0.23
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	LIMN	S&P 500	Difference	LIMN per year	S&P 500 per year
1 month	-12.3%	-3.0%	−9.3 pts
3 months	-60.1%	-2.8%	−57.3 pts
Year to date	-90.2%	+11.5%	−101.7 pts
1 year	-94.4%	+13.5%	−107.9 pts
3 years	-99.4%	+77.7%	−177.1 pts	-82.0%	+21.1%
5 years	-99.4%	+72.6%	−172.0 pts	-63.9%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M LIMN shares were sold short on Oct 30, 2026, up 20.9% from the previous report. At recent volumes it would take 1.6 days to buy them back. Over the last 20 sessions, 43.8% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	47,913	+20.9%	29,074	1.6
Oct 15, 2026	39,632	-11.1%	21,523	1.8
Sep 30, 2026	44,566	-24.2%	24,512	1.8
Sep 15, 2026	58,817	-38.4%	27,526	2.1
Aug 31, 2026	95,505	-99.1%	71,248	1.3
Aug 14, 2026	10,331,073	+144.0%	60,973,817	1.0
Jul 31, 2026	4,234,144	+76.1%	52,873,116	1.0
Jul 15, 2026	2,404,454	+106.0%	75,297,149	1.0
Jun 30, 2026	1,167,107	+28.2%	7,729,303	1.0
Jun 15, 2026	910,412	-25.9%	4,005,524	1.0
May 29, 2026	1,228,229	+118.4%	44,575,019	1.0
May 15, 2026	562,363	-48.1%	643,391	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?